Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investiga...
SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by cert...
Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm
NEW YORK , May 19, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS) breached their fi...
Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript
Doximity, Inc. (NYSE:DOCS ) Q4 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Perry Gold - Head of IR Jeff Tangney - Co-Founder and CEO Anna Bryson - CFO Nate Gross - Co...
Doximity (DOCS) Surpasses Q4 Earnings and Revenue Estimates
Doximity (DOCS) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.25 per share a year ago.
Doximity Stock Drops 20% After Outlook Disappoints
Shares of Doximity plummeted late Thursday after the telehealth software company dished out a disappointing outlook.
Doximity Q4 Earnings Likely to Reflect Strong Product Momentum
Doximity's Q4 performance likely witnessed strong product-driven gains from new modules and integrated programs, though early revenue pull-forward might have tempered sequential growth.
Doximity (DOCS) is an Incredible Growth Stock: 3 Reasons Why
Doximity (DOCS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Why Doximity (DOCS) Might be Well Poised for a Surge
Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Doximity Stock Skyrocketed Higher Today
According to data provided by S&P Global Market Intelligence, the "Bloomberg platform for medical professionals," Doximity (DOCS 33.69%), saw its shares spike 34% as of 11:20 a.m. ET Friday.
Doximity (DOCS) Q3 Earnings and Revenues Top Estimates
Doximity (DOCS) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.29 per share a year ago.
The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC
Doximity, Omnicell, Embecta, Cencora and EDOC are included in this Analyst Blog.
Doximity: Upgraded To Buy Amid Promising Growth And Strong Execution
Upgraded Doximity to a buy rating due to recent share price pullback, stronger engagement metrics, and deeper client relationships, creating a compelling entry point. DOCS reported 20% y/y revenue ...
Doximity (DOCS) Ascends But Remains Behind Market: Some Facts to Note
Doximity (DOCS) closed the most recent trading day at $58.18, moving +0.61% from the previous trading session.
Doximity: Strong Fundamentals And Growth Potential Makes It Attractive
Doximity's dominance in digital healthcare is evident with over 80% of U.S. doctors using the platform, driving strong network effects and competitive positioning. The company boasts impressive fin...
Buy 5 High-Flying Health & Fitness Stocks of 2024 With More Upside
Five Health & Fitness stocks have strong growth potential for 2025. These are GRMN, SFM, DOCS, PLNT and PTON.
Related Companies